Immunogenicity of Extended mRNA SARS-CoV-2 Vaccine Dosing Intervals.
Where this comes from
- Record sourced from PubMed, PMID 34860253.
- Also identified by DOI 10.1001/jama.2021.21921 and PMC identifier 8642809.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This study investigates the immunogenicity of extended mRNA vaccine dosing intervals.
Medical subject headings
- 2019-nCoV Vaccine mRNA-1273
- BNT162 Vaccine
- Immunization Schedule
- SARS-CoV-2